Goldman Sachs recognized co-founder and CEO of Geneoscopy, Andrew Barnell as one of 100 entrepreneurs. Barnell began his career with J.P. Morgan’s healthcare investment banking group, working primarily on M&A and capital markets transactions.

“Innovation doesn’t happen just anywhere; it thrives where there’s a wide range of thoughts and perspectives,” said David M. Solomon, Chairman & CEO of Goldman Sachs. “One of our great strengths is our ability to bring together people from different walks of life and to spark conversations today that will lead to breakthroughs tomorrow.”

Prior to co-founding Geneoscopy, he was an associate at Lindsay Goldberg, a middle-market private equity firm focused on partnering with family-owned businesses. Barnell holds a BA in Applied Economics and Management, with a specialization in Finance, from Cornell University and earned an MBA in Health Care Management and Entrepreneurial Management from The Wharton School.

“With an initial focus on colorectal cancer prevention, Geneoscopy’s technology is poised to transform gastrointestinal health by enabling earlier detection, more accurate diagnosis, and more effective therapeutic management,” said Vince Wong, Geneoscopy’s Chief Commercial Officer in a press release. “It is exciting to have Andrew’s vision for the company recognized, validating the significant impact it will have on shaping the future of gastrointestinal health.”